Qube Research & Technologies (QRT)
OKUR

Qube Research & Technologies (QRT)’s OnKure Therapeutics OKUR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,663
Closed -$80.3K – 4072
2025
Q1 		$80.3K Buy
+18,663
New +$105K ﹤0.01% 3030
2024
Q3 		– Sell
-1,422
Closed -$21.5K – 4284
2024
Q2 		$21.5K Buy
+1,422
New +$24.1K ﹤0.01% 2871
2024
Q1 		– Sell
-543
Closed -$8.68K – 4954
2023
Q4 		$8.68K Buy
+543
New +$33.8K ﹤0.01% 3626
2022
Q1 		– Sell
-1,348
Closed -$115K – 3113
2021
Q4 		$115K Buy
+1,348
New +$99K ﹤0.01% 2109

Other funds holding OKUR

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s OKUR Position: Q2 2025 in Review

Qube Research & Technologies (QRT) sold out of OnKure Therapeutics (OKUR) in Q2 2025, closing a stake of 18,663 shares — an estimated $80.3K sold.

Qube Research & Technologies (QRT) first reported a position in OKUR in Q4 2021 and held it in 4 quarters. The position peaked at $115K in Q4 2021. 49 funds tracked by Wall St. Rank hold OKUR as of Q2 2025.

  • Qube Research & Technologies (QRT) reported no remaining OnKure Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 18,663 OnKure Therapeutics shares in Q2 2025, an estimated $80.3K.
  • Qube Research & Technologies (QRT) first reported a position in OnKure Therapeutics in Q4 2021 and held it in 4 quarters.
  • Qube Research & Technologies (QRT)'s OnKure Therapeutics position peaked at $115K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.